Evolus (EOLS) Other Non-Current Assets (2017 - 2026)

Evolus (EOLS) reported Other Non-Current Assets of $1.6 million for Q1 2026, up 83.11% on a YoY basis from $900000.0 in Q1 2025, and up 37.45% quarter-over-quarter from $1.2 million in Q4 2025.

Evolus (EOLS) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Evolus has reported Other Non-Current Assets for 10 years, with the latest figure at $1.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 83.11% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 83.11% YoY), and the FY2025 full-year result was $1.2 million, up 39.74% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $1.6 million, up from $1.2 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $2.8 million in Q4 2022, with the low at $222000.0 in Q3 2023.
  • Historically, Other Non-Current Assets has averaged $1.4 million across 5 years, with a median of $1.2 million in 2025.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 1005.83% — and 2023, when it plunged 91.25%.
  • Evolus' Other Non-Current Assets stood at $2.8 million in 2022, then plunged by 85.46% to $409000.0 in 2023, then surged by 109.78% to $858000.0 in 2024, then soared by 39.74% to $1.2 million in 2025, then soared by 37.45% to $1.6 million in 2026.
  • The last three Other Non-Current Assets figures came in at $1.6 million (Q1 2026), $1.2 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.79 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 59.36 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 47.63 Mn
10 Evolus 435.45 Mn 385.65 Mn 48.90 Mn 1.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.65 Mn
Dec 31, 2025 1.20 Mn
Sep 30, 2025 1.58 Mn
Jun 30, 2025 1.80 Mn
Mar 31, 2025 900,000.00
Dec 31, 2024 858,000.00
Sep 30, 2024 858,000.00
Jun 30, 2024 409,000.00
Mar 31, 2024 409,000.00
Dec 31, 2023 409,000.00
Sep 30, 2023 222,000.00
Jun 30, 2023 223,000.00
Mar 31, 2023 2.68 Mn
Dec 31, 2022 2.81 Mn
Sep 30, 2022 2.43 Mn
Jun 30, 2022 2.55 Mn
Mar 31, 2022 2.65 Mn
Dec 31, 2021 2.76 Mn
Sep 30, 2021 240,000.00
Jun 30, 2021 240,000.00